ND Capital is a venture capital firm that focuses on investing in disruptive technologies across the life, physical, and data sciences. Their strategy is based on the belief that scientific disciplines will converge, leading to significant breakthroughs, and they invest across various sectors, stages, and technologies in the United States and Europe.
38% of their portfolio is in Healthcare. Average disclosed round size is $54.3M (across 7 rounds with reported amounts).
Portfolio
8
Fund Size
$800M
Top Stage
Series E
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
8 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Visby Medical | Growth | $55M | Jun 2025 |
 Constructive Bio | Series A | $58M | Sep 2024 |
| LLightcast Discovery | Series B | $49M | Aug 2023 |
| Visby Medical | Series E | $35M | Jun 2022 |
| Visby Medical | Series E | $135M | Jun 2022 |
 IONpath, Inc. | Series B | $18M | Sep 2020 |
 SiMa.ai | Series A | $30M | May 2020 |
 Altitude Trampoline Park | Unknown | — | Dec 2018 |
Top Co-Investors
Cedars Sinai Medical Center3 shared
Blue Water Life Science Advisors3 shared
J2 ventures2 shared
Paladin Capital Group2 shared
Samsara BioCapital1 shared
The Vertical Group1 shared
Lightrock1 shared
M Ventures1 shared
ARCH Venture Partners1 shared
Illumina Ventures1 shared
Fine Structure Ventures1 shared
Dell Technologies Capital1 shared
Amplify Partners1 shared
Wing1 shared
Catalio Capital Management1 shared
Last updated: 16 April 2026